There was a nonsignificant trend toward prolonged survival in patients with low or high levels of MVPA-SL compared with no MVPA-SL (HR adj : 0.58; 95% CI = 0.32 to 1.04) and 0.48; 95% CI = 0.27 to 0.89), respectively; Figure 1, B ).
← all excerpts
Physical activity and checkpoint inhibition: association with toxicity and survival.
1
—
—